Notably, the study also found ETI modulates ion channels in Aspergillus biofilms, as ETI-induced permeability and biomass reduction were partially mitigated by a mammalian CFTR inhibitor GlyH-101, suggesting a direct biological mechanism for ETI’s antifungal activity in CF patients. Here, CFTR is linked to cystic fibrosis.